Comparative clinical characteristics among different age group of adult COVID-19 patients: A multicenter study

Wei Cheng1, Yating Peng1, Aiyuan Zhou2

  • 1Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

Insights

The risk of severe COVID-19 increases with age, with older adults experiencing more critical illness. Chronic heart disease, high heart rate, and respiratory rate also significantly elevate the risk for severe coronavirus disease (COVID-19).

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Clinical Medicine

Background:

  • Coronavirus disease (COVID-19) presents a significant global health challenge with substantial morbidity and healthcare expenses.
  • Understanding clinical variations across different adult age demographics is crucial for effective management.

Purpose of the Study:

  • To compare the clinical features of adult COVID-19 patients across various age strata.
  • To identify age-related differences in disease presentation and severity.

Main Methods:

  • Retrospective analysis of laboratory-confirmed COVID-19 cases in adults from December 2019 to March 2020.
  • Patients were categorized into five distinct age groups for comparative analysis.

Main Results:

  • The proportion of severe or critical COVID-19 cases significantly increased with advancing age groups.
  • Dyspnea was the only symptom with statistically significant differences between the elderly and younger groups (p < .001).
  • A history of chronic heart disease (OR: 56.038), older age (OR: 1.055), elevated heart rate (OR: 1.085), and respiratory rate (OR: 1.635) were independently associated with severe or critical COVID-19 outcomes.

Conclusions:

  • Severity of COVID-19 correlates positively with older age groups.
  • Factors such as advanced age, pre-existing chronic heart disease, and elevated vital signs upon admission are critical indicators for severe COVID-19.
Abstract

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
21
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
690
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
29
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
14
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
19